Limits are being placed on profits doctors can make on some cancer drugs, causing oncologists to search for new income. Some fear these physicians may resort to prescribing additional treatments for some patients. Not just any treatments, though -- just the ones with the best reimbursements.

Until 2005, Medicare paid a markup of 20 to 100 percent for many cancer drugs. In 2005, Congress changed the reimbursement system to pay physicians just six percent more than the average price for a given treatment. This decrease has made it difficult for small practices to break even on cancer drug purchases because the purchases are not large enough to receive rebates or discounts from drug manufacturers.

According to a recent New York Times article, some oncologists have attempted to increase profits by performing chemotherapy more often, ordering more diagnostic scans, and by putting pressure on patients to make out-of-pocket drug co-payments.

Say it isn't so.

Major League Baseball and the Prostate Cancer Foundation teamed up this year to form the Home Run Challenge in honor of Father's Day. Their gift to father's across the country: for each home run hit in 60 selected games between June 6 and today, June 17, raised money for prostate cancer, the second most common cancer for men in the United States.

Some fans of this cause made pledges; some posted online tributes to their dads at Dockers San Francisco. For every message submitted, the company donated one dollar. Some messages were even shown in Times Square for all to see.

I just checked the status of the Home Run Challenge on this Father's Day morning and found the most updated total of home runs to be 91. Leading the accomplishment are Ken Griffey, Jr., Alex Rodriguez, and Alfonso Soriano. The current Team Home Run leader: the Cincinnati Reds.

Movie critic Roger Ebert expects to be back to work at his annual festival for overlooked movies this week. It will be his first public appearance since having cancer surgery last summer -- and while some say his appearance may attract the gossip papers, Ebert says, "So what?"

Ebert, 64, will be seen at the ninth annual Overlooked Film Festival, beginning today at the University of Urbana-Champaign, wearing a gauze bandage around his neck. And his mouth will be seen to droop, he says.

This is all because of Ebert's tracheostomy -- it opens an airway through an incision in his windpipe, rendering him speechless -- that resulted from his June 16 surgery to remove a cancerous growth on his salivary gland and a subsequent July 1 surgery to repair a burst blood vessel close to the same site.

On Tuesday, Ebert shared that his cancer began in his salivary gland but then spread to his lower right jaw. As a result, part of his mandible was removed and two surgeries were necessary to reconstruct the area. Both surgeries were unsuccessful, however, and led to unanticipated bleeding.

"The doctors now plan an approach that does not involve the risk of unplanned bleeding," Ebert, a film critic for the Chicago Sun-Times since 1967, says. "If all goes well, my speech will be restored."

This cancer survivor, who says we spend too much time hiding illness and is proud to be back in the spotlight, has also co-hosted the Ebert & Roeper television show with fellow Sun-Times columnist Richard Roeper since 2000. Film critics and filmmakers have been filling in for Ebert during his recovery.

Nabilone, known as Cesamet, a synthetic imitation of an active ingredient found in marijuana, has been shown successful in treating cancer patients experiencing nausea, pain, anxiety and depression, according to University of Toronto researchers who conducted a study on the effectiveness of the synthetic drug.

During the study of 139 participants, a survey was conducted to rate how well the synthetic drug alleviated the adverse side-effects most commonly associated with chemotherapy. According to the study, cancer patients who were prescribed Cesamet indicated less pain, anxiety and depression.

A prescription drug approved for cancer patients who do not respond to traditional anti-nausea treatments, lead investigator Dr. Vincent Maida stated, "This is not a pot pill and has absolutely no street value."

The trouble with the synthetic drug, which is legal, is the stigma attached to marijuana use in general, even on the part of some physicians, who are said to be hesitant to prescribe a version of marijuana even if it is not marijuana. In our modern society, marijuana is sometimes associated with counter-culture populations, addiction and even as a gateway to more addictive drugs.

I would say I just do not get it when it comes to the denial of making cancer treatment for a cancer patient a little easier, but The Scientific American published a brief history of marijuana that brings us from ancient China to the present with, "In 1937 the U.S. Congress, against the advice of the American Medical Association, passed the Marijuana Tax Act, effectively banning use of the drug by making it expensive and difficult to obtain. Ever since, marijuana has remained one of the most controversial drugs in American society. Despite efforts to change its status, it remains federally classified as a Schedule 1 drug, along with heroin and LSD, considered dangerous and without utility."

As anyone who has undergone the grueling ordeal of chemotherapy can tell you, getting high is the last thing on their mind. However, alleviating the debilitating side effects of chemotherapy is critical.

Other medical marijuana-related posts include:

• Montel Williams: poster child for pot
  
• Medical marijuana pot pill approved for chemotherapy
• Breast cancer has made me a criminal patient story
• FDA rejects medical marijuana use
• Guru of Ganja: medical marijuana advocate faces new pot charges

Gerald Boyd, the first black managing editor of The New York Times, the man forced to resign two years after his appointment -- during a reporter's plagiarism scandal -- died Thursday of lung cancer. He was 56.

Boyd was diagnosed with cancer in February and while he was sick for most of the year, he kept his condition private from most friends and colleagues.

Boyd is credited for his ability to mobilize a reporting team and surround a story to capture every important fact. He was tough and demanding and had a huge heart. And while he left the paper under sad circumstances, he also left as a well-respected newsman.

Boyd became managing editor in 2001 and resigned in 2003 after the discovery that reporter Jayson Blair had plagiarized material, invented quotes, and wrote stories using datelines of places he'd never seen. The scandal resulted in discontented staff members who lost confidence in Boyd's leadership.

After his resignation, Boyd became involved in several projects and found himself writing a column for Universal Press Syndicate. His goal -- to help people understand how newsroom decisions are made.

Boyd is survived by his wife and 10-year-old son.

Bathsheba's Breast: Women, Cancer and History is a history lesson on breast cancer.

In 1967 an Italian surgeon looked at Rembrandt's painting Bathsheba at her bath (front cover on book) and concluded that she had died of breast cancer. The woman in the painting was Rembrandt's mistress and showed signs in the painting of pitted skin on the breast and swollen lymph nodes. You can actually see what the surgeon saw when you look at the painting.

This is what is written about on the front flap of the book - it caught my attention instantly. Even though I have thought in my mind what it must have been like in the past to have had breast cancer, I really wasn't aware of how far back they can track the disease. We know that not so far back in our day when women didn't talk about breast cancer. Can you imagine what it was like in ancient times?

It's come a long way - but I wanted to know the path that has led us to today's breast cancer surgery and treatment. They did have some crazy remedies back then and some women died rather than have their breast removed. Removed with no pain killers or sterilization I might add.

The book keeps us going through the centuries and decades and what led to the changes in breast cancer treatment that we see today.

Hair colorist Jason Backe hopes hair dye does not cause cancer -- because he is covered in it every day in the Manhattan hair salon where he works. But the topic of hair dye and cancer has been on his mind lately -- because he has been fielding questions from clients about the possible link between the two ever since an American Journal of Epidemiology study was released and caused nationwide panic about hair dye upping the odds that women might contract lymphoma -- a cancer of the lymphatic system. But on Thursday, a New York Times article summed up opinions from both experts and hair stylists, revealing that most everyone believes this panic is not necessary.

Recent studies found that those who had ever used hair dye were 1.19 times more likely to get lymphoma than those who had never used it. Those who colored their hair before 1980 -- before then-questionable chemicals were removed from hair dyes -- were 1.39 more times likely to get the disease. Ann Curry on the Today Show said, "These are scary numbers," but Dr. Barnett Kramer, associate director for disease prevention at the National Institute of Health said, "Compared to risk factors for other diseases, those numbers are very small." Smoking makes people 10 to 60 more times likely to get lung cancer. According to Dr. Joseph K. McLaughlin, president of the International Epidemiology institute, if these numbers are true -- and that's a big if -- it would mean that using hair dye may present a remote risk to your health. But it would still be less risky than crossing a street, driving a car, not wearing a seat belt, or drunk driving.

I am not exactly in a panic about this whole issue. But before I heard the news about hair dye and cancer, I did dye my hair -- once. And I don't think I will do it again -- even though the risk may be small -- because I have already had cancer. And any amount of risk associated with any type of cancer is just something I don't want to mess with.

I never colored my hair -- until after cancer, when my once-blond hair lost to chemotherapy grew in mousy brown with touches of gray. I thought it needed some spark and dazzle so I doused my head -- and my bathroom counter and walls too -- with hair dye in an effort to brighten up my look. It worked. And I like it. But I don't like what I've now heard about a possible link between hair dye and cancer. And this is what I told a reporter from the New York Times who called me the other day. She had read my post here on the Cancer Blog about this news story -- about hair dye and cancer -- and she wanted to know more about my personal feelings as a cancer survivor and as a person with colored hair.

I told this reporter that it's a bit ironic that in 36 years, I had never applied hair dye to my hair and that only after cancer did I take the plunge -- only to learn that hair dye may be cancer causing. I told her that I wouldn't do it again -- dye my hair -- although I don't think one application of coloring chemicals will really affect me when research indicates a risk only when women use hair dye 12 or more times. But still, I don't choose to take even the smallest of risks when it comes to my health -- which has already been compromised once. I told the reporter that I have not witnessed any widespread panic among the public about this issue. And I think the people I know who color their hair will continue to do so. That's okay with me. Because when it comes down to it, I am responsible for my hair only, my health only, my life only. That's really all I can manage.

And once my colored hair grows out -- the colored hair that was photographed today for the story this reporter is writing -- I'll manage to live on with my mousy brown hair with natural gray highlights. It won't have much spark or dazzle. But it will be safe.

On Monday, the sale of a Japanese brand of aloe juice was banned by the Department of Health after it was determined that it contains high levels of benzene -- seven times more than the World Health Organization recommends for maximum levels in water. Benzene is a colorless and flammable liquid with a sweet smell and was once used as an additive in gasoline. It is carcinogenic -- and has been cause for concern worldwide. So samples of the drink, produced by the Japansese cosmetics brand DHC, will be sent to the Bureau of Food and Drug Analysis for further investigation due to such concerns. In the meantime, the sale of this aloe juice, sold in convenience stores and through mail-order, will be suspended.

Caregivers are affected by cancer in their own unique and special ways. And those of us who have never been cancer caregivers and those of us who are patients receiving the care will never really know how it feels to walk in caregiver shoes -- until we do it ourselves.

Dr. Mitchell Luftig has done it himself. And after traveling a dark and unwanted journey of caring for his wife with breast cancer, he realized that he had learned a thing or two -- and he learned that he could share a thing or two. So he wrote a book, Be a Hero To The Woman You Love When She Gets Sick, and he speaks openly about his role as caregiver -- and his role at the time as father of twin high school daughters and husband of 20 years and clinical psychologist too. The whole ordeal turned his world upside down and he hopes that his story helps others -- primarily men -- who find themselves in a lonely place with the daunting job of caring for the people they love. As a psychologist, Luftig has good insight. And he wishes to help minimize the psychological barriers that prevent men from effectively caring for loved ones during times of serious illness.

Luftig shares in his book his realization that while he cannot repair and fix all hard times, he does have some important tools. And his power tools are love, support, and understanding. He has learned to sew joy out of rough cloth. He understands that he cannot shelter his family members from bad times, but he can shoulder their burden. And he now appreciates that all things are not so bad when measured against the yardstick of a life-threatening disease like cancer. Luftig's whole collection of wisdom and lessons and advice fill his book -- and bits and pieces also appear in periodic articles in Coping magazine. It's worth the read -- and the journey starts here.

Back in March, we shared the story of Peter Cura, an otherwise healthy carpenter who suddenly began experiencing severe back pain. Before that, he rarely got a cold but he knew something was wrong.

At 31, Cura died from complications of kidney cancer, after doctors repeatedly misdiagnosed his kidney cancer 37 times. They told him he had kidney stones. Cura kept insisting on a CAT scan and by the time the doctors agreed, and discovered it was kidney cancer, it was too late.

The statement issued by the Medway Maritime Hospital, "Medway NHS Trust would again like to express its heartfelt and sincere condolences and regrets to the family of Mr Cura. Mistakes were made and nothing that the Trust can say will alleviate the suffering and loss experienced by this family. However, lessons have been learned from this tragic case," is little comfort to Cura's widow Julia, or his two small children, Lewis, six, and Abigail, three.

Julia says the youngest child keep asking when daddy is coming home, and the older boy has grown quiet and withdrawn. She is vowing to fight on for justice in this matter. The hospital and doctors who saw and treated Cura have not been held accountable. According to Julia, the hospital has stated that her husband would have died anyway. Given the circumstances leading up to his death, that seems an entirely wrong and insensitive position to take and the incredulous realities of this story just keep coming to light.

I woke yesterday morning to voices on the Today Show telling me that the use of hair dye is linked to incidences of lymphoma -- a general term for a group of cancers that originate in the lymphatic system. I know I've heard in the past about the possible link between cancer and the chemicals that add color to hair -- but the connection has never been revealed as very strong and the topic did not ever apply to me so I filed the information in the back of my mind. But now, it appears the link may be stronger than originally thought -- and I recently dyed my own post-chemo brown hair -- so I listened more intently this time and learned about the study that implies that touching up my roots may not be a wise practice.

The results of a European study, appearing in the July 1 issue of the American Journal of Epidemiology, reveal that roughly 10 percent of lymphomas in women could be caused by the use of hair dyes. The data suggest a small increase in risk -- and clearly more research is necessary -- but what researchers have found is that for the women who have dyed their hair more than 12 times, the risk is highest. And those who colored their locks before 1980 have the greatest risk. Since 1980, chemicals thought to be cancer-causing were eliminated from dyes -- although it is still not definite whether or not current hair dyes are risk-free. It is definite, say researchers, that further study of this topic is important. In the meantime, I think I will let my artificial reddish chestnut hues fade away while I enjoy the plain brown hair that covers my once-bald scalp.

Almost two months ago, we posted that the U.S. Food and Drug Administration, FDA, was fast-tracking a potentially promising new drug to help smokers quit smoking. In earlier clinical trials, Chantix, varenicline tartrate, worked in ways that previous smoking cessation drugs did not, indicating a higher success rate where other drugs had failed.

Chantix acts on the areas of the brain affected by nicotine and helps those who smoke cigarettes to quit smoking in two ways: by providing some nicotine effects to ease the withdrawal symptoms and by blocking the effects of nicotine from cigarettes if they start smoking again.

Now, according to three studies published in the July 5 Journal of the American Medical Association, it is being reported that Chantix quadruples the chances that a smoker can quit smoking and is twice as effective as the currently prescribed drug Zyban. Keep in mind though, the research was funded by the drug maker, Pfizer, and experts warn that the drug is far from a perfect solution for smokers trying to quit -- and "definitely not a panacea for smoking cessation."

According to Dr. Steven Galson, Director of FDA's Center for Drug Evaluation and Research, "Chantix therapy has proven to be effective in smokers motivated to quit and will provide another tool for physicians to use for the millions of smokers who want to quit." I believe this is a more realistic assessment of the ability of a medication designed to help smokers quit smoking.

UPDATE: Chantix: quit smoking drug now available in US pharmacies.

When Amy Turner Tunick, an actress and writer who wrote The Feel Good Column for the South Florida Sun-Times, was first diagnosed with cancer she wrote:

"It doesn't seem real. There were no signs or symptoms. Maybe it's a genetic thing. But will I ever really know? I've been a very healthy active 44 year-old woman. I don't drink or smoke.  But, sometimes, unfortunate things do happen to good people. And I don't doubt I'm a good person. Actually, I believe I'm an exceptional person. I'm positive, optimistic, inspiring and enthusiastic. I try to be caring, loving and honest. So, sadly, I'm not blaming anyone, including God, that I've just been diagnosed with pancreatic cancer." 

Tunick did not exaggerate when she described herself as a positive, optimistic, inspiring and enthusiastic person. Her columns reflected that, and she had a way of inspiring the reader to feel optimistic about life. She had a way of reminding you of the simple joys of life and the importance of the people in your life. In one of her last columns, she wrote, ''Cry, scream, feel sorry for yourself -- but not for long. Basically, this is all about hope. Never lose it. Never give in or give up.''

Tunick had this to say about death, "I believe that Death teaches us that the time is now. The time is now to pick up a telephone and call the person that you love. Death teaches us the joy of the moment. It teaches us we don't have forever. If teaches us that nothing is permanent. It teaches us to let go, there's nothing you can hang on to. And it tells us to give up on expectations and let tomorrow tell its own story, because nobody knows if they'll get home tonight."

Tunick won't be getting home tonight. She lost her battle to cancer and the world lost more of its light. Tunick was 47.